/api/archive/snapshots/7ead5dcbf59b840d827f679957023d49f5b12b554f085a09ce68ff952a9ca023/page.html
View dossier →Brian Lum alias Histamine Stacksmith
Instagram · 9749039445
Practice location
18122 West 119th Street
Olathe, KS 66061
Funnel-first framing that runs on persuasion, light on published evidence.
- Of 7 health claims, 4 run counter to or conflict with the published evidence, and 2 were not independently checked.
- Primary persuasion tactic: Course launch funnel.
- Stated credentials look inflated relative to the advice given.
- Profits from the products and labs they recommend, with no clear disclosure.
- Gives advice beyond what their license covers.
Brian Lum is serving up the full functional-fitness-meets-chronic-illness carousel: a complex-condition course, a mystical 'specialist' identity, and the inevitable favorite-supplement side quest. It’s the old move — turn a messy symptom cluster into a branded framework, then sell the framework and the stack.
High grift signals
Score breakdown
Direct answer
Brian Lum is licensed in Kansas as a chiropractor (DC), not as an MD or DO, and Kansas's chiropractic scope statute (K.A.R. 100-6-4 (Applications for licensure in the healing arts); K.S.A. 65-2801 et seq. (healing arts definitions, not expressly authorizing systemic internal-disease specialty practice for chiropractors)) limits that license to musculoskeletal care, not the diagnosis or treatment of systemic disease. Even so, they advertise diagnosing or treating course on histamine intolerance and MCAS, The 5 Game-Changers for Healing Histamine, supplement protocol for histamine symptoms, and clinical protocols developed by Dr. Lum, conditions that belong with appropriately board-certified physicians. Those same pages route patients toward supplements and paid programs that Brian Lum profits from.
Key findings
- Sales Funnel Motive: This is a direct product launch, not neutral education. The post steers viewers from a symptom narrative into a paid course enrollment.see section ↓
- Claim "Mastering Histamine Intolerance and Mast Cell Activation Syndrome: A Complex Illness Spec…": not supported by peer-reviewed evidence.see section ↓
- Claim "clear framework for understanding and addressing histamine-related illness": mixed in the medical literature.see section ↓
- NPI registry confirms Brian Lum as Chiropractor (DC) in Kansas (NPI 1639421845).see section ↓
- Brian Lum shows credential inflation relative to stated vs likely credentials.see section ↓
- Dr Brian Lum is marketed with a doctor title, but reviewed credentials indicate Chiropractor (DC) rather than an MD/DO physician license.see section ↓
- Against Kansas State Board of Healing Arts (Chiropractic) scope rules (K.A.R. 100-6-4 (Applications for licensure in the healing arts); K.S.A. 65-2801 et seq. (healing arts definitions, not expressly authorizing systemic internal-disease specialty practice for chiropractors)), these advertised…see section ↓
- 12 of 13 advertised activities fall outside permitted Chiropractor scope in KS.see section ↓
Claims & evidence
8 advertised conditions or treatments fall outside their license scope. Each box leads with state-board scope notation; literature cross-check follows when we matched a specific claim. Every card carries its receipts: the quoted wording, a live source link, and an archived copy.
Brian Lum is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to advertise Mastering Histamine Intolerance and Mast Cell Activation Syndrome: A Complex Illness Specialist’s Guide as within their scope of practice.
Mastering Histamine Intolerance and Mast Cell Activation Syndrome: A Complex Illness Specialist’s Guide
- Supports
- The claim is a topic heading rather than a factual medical assertion, so there is no direct therapeutic or diagnostic proposition to verify. The indexed literature supports that histamine intolerance and non-clonal mast cell activation syndrome are clinically discussed as overlapping but distinct entities, which fits the idea that they are complex and often require specialist evaluation. Reviews also support that mast cell activation is not explained by histamine and tryptase alone, implying a broader and more nuanced biology than simplified influencer content usually conveys. Systematic review-level evidence exists for MCAS presentations, including anaphylaxis in some patients, which supports that mast cell disorders can be clinically significant and heterogeneous.
- Contradicts
- No indexed paper supports a broad claim that an influencer can ‘master’ histamine intolerance or MCAS in a reliable, standardized way, because these conditions remain diagnostically contested, heterogeneous, and often lack universally accepted biomarkers. The comparison paper emphasizes overlap and differential diagnosis rather than a simple unified syndrome, which weakens any oversimplified management claim. Reviews of mast cell activation also indicate that current understanding goes beyond histamine and tryptase, which contradicts reductionist advice focused only on histamine avoidance or single-test diagnosis. The available evidence base is largely review-oriented, and the absence of major guideline-level, high-certainty interventional evidence in the provided index means claims of authoritative “specialist” mastery are not well supported. Some literature on secondary or primary mast cell activation syndromes is classificatory rather than treatment-validating, so it does not establish practical mastery claims.
- Mainstream view
- Mainstream medicine recognizes mast cell activation disorders and histamine intolerance as real clinical considerations, but both remain diagnostically complex and somewhat controversial, especially histamine intolerance and non-clonal MCAS. The prevailing view is that evaluation should be individualized, based on symptoms, exclusion of alternative diagnoses, and careful specialist assessment rather than on simple influencer-style protocols.
“Mastering Histamine Intolerance and Mast Cell Activation Syndrome: A Complex Illness Specialist’s Guide”
Rule: K.A.R. 100-6-4 (Applications for licensure in the healing arts); K.S.A. 65-2801 et seq. (healing arts definitions, not expressly authorizing systemic internal-disease specialty practice for chiropractors)
Brian Lum is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to advertise histamine intolerance and MCAS are often misunderstood as within their scope of practice.
histamine intolerance and MCAS are often misunderstood
No specific health claims of theirs were cross-checked against the literature.
“histamine intolerance and MCAS are often misunderstood”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Brian Lum is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to advertise clear framework for understanding and addressing histamine-related illness as within their scope of practice.
clear framework for understanding and addressing histamine-related illness
- Supports
- There is emerging evidence that clinicians and researchers are attempting to build a more structured framework for histamine-related illness, particularly under the label histamine intolerance (HIT). Reviews and position papers describe consistent elements: typical symptom clusters across multiple organ systems, the importance of excluding alternative diagnoses (IgE-mediated food allergy, mastocytosis, other gastrointestinal and systemic diseases), and the use of a low-histamine diet, sometimes combined with DAO supplementation or antihistamines, as both diagnostic and therapeutic tools. Several recent narrative reviews outline stepwise diagnostic algorithms that start with symptom history, exclusion of other causes, and then trial of low-histamine diet with monitoring of response, which does constitute a framework, albeit largely consensus-based rather than rigorously validated.[11][15][16] Some guidelines and position papers (e.g., German guideline/position paper on adverse reactions to ingested histamine) also propose pragmatic pathways for evaluating suspected histamine-related reactions, emphasizing differential diagnosis, cautious use of elimination diets, and limited reliance on laboratory tests, which is a form of clinical framework.[6] More recent overviews highlight a multi-step clinical approach (history, ruling out allergy and mast cell disease, dietary trial, possible provocation tests, and adjunctive laboratory measures like DAO or histamine metabolites), which can reasonably be described as a “clear” or at least structured framework for practice, even though many components lack strong validation.[11][12][13][16]
- Contradicts
- High-quality evidence (RCTs, large prospective studies, or fully validated diagnostic criteria) for histamine-related illness is limited, and several authoritative sources explicitly state that histamine intolerance is not yet a well-defined nosological entity and that scientific deficits are substantial.[15][6] The German guideline/position paper notes that the link between ingested histamine and non-allergic adverse reactions is supported by limited evidence and that a reliable, objective laboratory test for diagnosis is lacking, which directly contradicts any implication that there is a robust, fully evidence-based framework comparable to other established diseases.[6] Reviews repeatedly stress that existing algorithms are based on expert opinion, small studies, and case reports, with wide variability in proposed tests (serum DAO, histamine 50-skin-prick test, urinary metabolites, provocation tests) and no consensus on cutoffs or diagnostic gold standard, which undermines claims of a clearly validated framework.[11][12][13][15][16] Some guideline authors warn that suspected histamine intolerance often leads to extensive and possibly unnecessary restrictive diets, and they question the reproducibility of symptoms after histamine ingestion, again showing that the conceptual framework remains contested and incomplete rather than clearly established.[4][5][6] Overall, while structured clinical pathways exist, they are not underpinned by high-quality RCTs or robust mechanistic validation, so a strong claim of a clear and evidence-backed framework overstates the current state of the science.
- Mainstream view
- The mainstream medical position is that histamine-related illness in the sense of chronic histamine intolerance or non-allergic adverse reactions to dietary histamine is a plausible but incompletely characterized clinical entity. Most expert reviews and guidelines agree that there is a recognizable pattern of symptoms in some patients and that a structured diagnostic approach (careful history, exclusion of allergic and other diseases, supervised low-histamine diet, and selected ancillary tests) is reasonable in practice.[11][12][13][15][16] However, mainstream opinion also emphasizes that scientific evidence remains limited, diagnostic markers (especially serum DAO) are not sufficiently validated, and histamine intolerance is not yet a formally established nosological unit with universally accepted criteria.[6][15] Major guidelines tend to frame management in cautious, pragmatic terms: avoid over-restrictive diets, prioritize ruling out other disease, and use elimination/provocation and symptomatic treatments as clinical tools, while acknowledging that more high-quality research is needed before histamine-related illness can be said to have a fully clear and robust evidence-based framework.[4][5][6][11][12][15]
“provide a clear framework for understanding and addressing histamine-related illness”
Rule: K.S.A. 65-2801 et seq. (healing arts definitions; chiropractic branch limited to chiropractic practice, not systemic internal disease management)
Brian Lum is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to advertise The 5 Game-Changers for Healing Histamine as within their scope of practice.
The 5 Game-Changers for Healing Histamine
- Supports
- The influencer’s phrase “5 game-changers for healing histamine” is too vague to map directly to specific interventions, but several evidence‑informed strategies for managing histamine intolerance or histamine‑mediated symptoms do have some support. Low‑histamine diet: Multiple narrative reviews and clinical overviews identify a low‑histamine diet as the current “gold standard” or keystone of treatment for suspected histamine intolerance, with symptom improvement in a substantial proportion of patients.[18] A recent quasi‑experimental and observational work and summarized data suggest that low‑histamine diets reduce gastrointestinal and systemic symptoms in the majority of patients with suspected histamine intolerance.[11][18] One review on histamine intolerance in children also reports that a histamine‑free or low‑histamine diet is the treatment of choice, with observed clinical benefit.[9][18] DAO (diamine oxidase) supplementation: Reviews of histamine intolerance consistently mention oral DAO supplementation as a subsidiary or complementary option for individuals with documented intestinal DAO deficiency.[2][18][15] Clinical summaries report that DAO supplementation can help break down ingested histamine and may benefit patients whose symptoms persist despite diet changes.[11][15][18] Short‑term antihistamines for severe or acute symptoms: Expert reviews on histamine intolerance and broader urticaria guidelines acknowledge that H1 (and sometimes H2) antihistamines can reduce acute histamine‑mediated symptoms, especially cutaneous and gastrointestinal manifestations, though their use for histamine intolerance itself is considered empirical.[12][18][19] Chronic urticaria and related mast‑cell–mediated conditions are strongly supported by high‑quality guidelines and consensus statements recommending second‑generation H1 antihistamines as first‑line therapy, with dose escalation and biologics (e.g., omalizumab) for refractory disease.[12][16][17][19] Trigger avoidance and multidisciplinary assessment: The German and other European guidelines for adverse reactions to ingested histamine emphasize systematic exclusion of other conditions, careful history, and elimination of suspected dietary triggers—including alcohol and certain medications that inhibit DAO—as part of management.[6][7][18] This structured approach, while not “game‑changing,” is evidence‑based and central to safe symptom control. Nutrient cofactors and supportive measures: Some reviews discuss supplementation with DAO cofactors (vitamin C, copper, vitamin B6) and probiotics as optional adjuncts, based largely on mechanistic rationale and small or uncontrolled data.[15][18] These are sometimes presented as “supporting histamine metabolism,” but supporting evidence is weaker than for diet and antihistamines. Overall, there is reasonable evidence that low‑histamine diet, DAO supplementation (especially in documented DAO deficiency), and short‑term antihistamines can improve histamine‑mediated symptoms or histamine intolerance in many patients, and these could plausibly be among “game‑changers” if defined as major management strategies, though the supporting evidence is mostly observational, quasi‑experimental, or based on expert consensus rather than large RCTs.
- Contradicts
- The influencer’s framing of “5 game‑changers for healing histamine” suggests definitive, curative interventions with strong evidence, which is not supported by current high‑quality literature. Uncertain disease entity and weak evidence base: German and international guidelines explicitly state that scientific evidence linking ingested histamine to a distinct, consistently reproducible clinical entity (often labeled “histamine intolerance”) is limited and that many perceived reactions are not objectively verifiable.[6][7] These guidelines highlight large deficits in understanding non‑allergic adverse reactions to histamine, a lack of reliable diagnostic laboratory tests (including DAO measurements), and problems with symptom reproducibility, calling into question the robustness of the diagnosis itself.[6][7] Lack of randomized trials for key interventions: Reviews note that treatment of histamine intolerance with antihistamines is empirical and that no randomized clinical trials have yet proven their benefit specifically for histamine intolerance as opposed to classic allergic or urticarial conditions.[13][18] Similarly, while low‑histamine diet and DAO supplementation are widely recommended, existing evidence rests on uncontrolled studies, case series, quasi‑experimental designs, or protocols, with high‑quality RCTs only recently being planned rather than completed.[3][5][11][18] Thus, describing these as proven “game‑changers” overstates the strength of evidence. Risk of over‑restrictive diets and oversimplification: Guidelines on suspected adverse reactions to ingested histamine caution that many patients end up on extensive elimination diets for
“The 5 Game-Changers for Healing Histamine”
Rule: K.S.A. 65-2801 et seq. (chiropractic defined as a branch of the healing arts without express authority to treat systemic histamine disorders)
Brian Lum is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to advertise Dr. Lum’s 5 Favorite Supplements for Healing Histamine as within their scope of practice.
Dr. Lum’s 5 Favorite Supplements for Healing Histamine
- Supports
- The influencer’s broad idea that certain supplements can help manage histamine‑related symptoms is partially aligned with emerging evidence, but support is limited and mostly focuses on diamine oxidase (DAO) supplements and low‑histamine diet rather than a generic “top 5” list of histamine‑healing supplements. A 2019 open‑label study of oral DAO supplementation in patients diagnosed with histamine intolerance reported significant improvement in symptom scores during supplementation, with worsening after DAO was stopped, suggesting a symptomatic benefit for at least some patients.[2] A 2025 evidence review on dietary management of histamine intolerance concluded that limited clinical evidence suggests a positive role for personalized low‑histamine diet and oral DAO supplementation in reducing symptoms associated with histamine intolerance, with all available studies reporting significant symptom reductions.[16] Recent protocols for large randomized trials are being developed specifically to test low‑histamine diet and DAO supplementation, reflecting that these interventions are considered sufficiently promising to warrant rigorous evaluation, though definitive RCT results are still pending.[1][3][10] Reviews of histamine intolerance note that diet modification and possibly DAO supplements are among the main pragmatic management approaches currently investigated in clinical practice, further supporting the idea that targeted nutritional approaches can modulate histamine‑related symptoms.[4][5][7][8][9][16]
- Contradicts
- There is no high‑quality evidence base for a specific branded “5 favorite supplements for healing histamine” protocol, and major reviews emphasize that histamine intolerance and mast‑cell–related disorders remain poorly defined and under‑researched, with diagnostic criteria and treatment strategies not yet standardized.[4][7][8][9][6] The existing DAO studies are small, mostly open‑label, and use heterogeneous diagnostic criteria and formulations; systematic reviews explicitly state that the clinical evidence for dietary management and DAO supplementation is limited and that further well‑designed trials are required, indicating that current data are insufficient to claim reliable “healing” rather than possible symptom relief.[16] A guideline on management of suspected adverse reactions to ingested histamine highlights that reliable laboratory tests (including serum DAO) are lacking, symptom reproducibility is poor, and the clinical picture of adverse reactions to ingested histamine is questionable, warning that many people follow extensive elimination diets and supplement regimens without solid evidence, which directly contradicts strong influencer claims of robust, proven histamine healing via supplements.[6] No major guideline or large randomized trial currently supports a standardized panel of multiple over‑the‑counter supplements as a primary or proven treatment for histamine intolerance or mast cell activation; instead, pharmacologic antihistamines and mast‑cell stabilizers remain the evidence‑based mainstays, with supplements considered adjunctive and experimental in most expert discussions.[7][9][13][15]
- Mainstream view
- Mainstream medical and scientific opinion is that histamine intolerance and related mast‑cell activation conditions are real but incompletely understood, with non‑specific symptoms, uncertain prevalence, and no universally accepted diagnostic criteria, so management must be cautious and individualized.[4][7][8][9][6] Major reviews and guidelines recommend first addressing potential alternative diagnoses, using a trial of low‑histamine diet and, in selected cases, DAO supplementation for symptom control, while acknowledging that the clinical evidence is limited and that more rigorous randomized trials are needed before firm conclusions can be drawn.[4][5][7][8][9][16][1][3][10] For mast‑cell–mediated diseases, the mainstream approach emphasizes H1 and H2 antihistamines, leukotriene antagonists, and mast‑cell–stabilizing drugs (such as cromolyn) as primary therapies, sometimes with vitamin D and calcium when there is bone involvement, and views non‑prescription supplements (flavonoids like quercetin, luteolin, curcumin; DAO; vitamin C) as potentially helpful but largely investigational and not substitutes for established pharmacologic management.[7][9][13][15] Overall, mainstream experts do not endorse influencer‑style “favorite supplement” lists as proven ways to heal histamine disorders; instead, they support cautious use of selected supplements on an adjunctive basis, within a broader, medically supervised plan that prioritizes evidence‑based drugs, dietary modification, and ongoing research participation when appropriate.[4][6][7][8][9][16][1][3][10] Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim).
“Dr. Lum’s 5 Favorite Supplements for Healing Histamine”
Rule: K.S.A. 65-2801 et seq. (healing arts definitions; no affirmative language granting chiropractors authority to treat systemic histamine disease)
Brian Lum is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to advertise bonus library of tried-and-true, yet highly innovative, clinical protocols developed by Dr. Lum as within their scope of practice.
bonus library of tried-and-true, yet highly innovative, clinical protocols developed by Dr. Lum
- Supports
- The claim is framed as a marketing phrase rather than a testable medical assertion, so there is no direct peer-reviewed evidence in the provided index papers that a “bonus library” of “tried-and-true, yet highly innovative, clinical protocols” developed by Dr. [12][14][15] Lum exists or has clinical value. Major evidence-based sources emphasize that clinical protocols should be specific to a defined question, pre-specified, and transparently developed or registered before use, rather than presented as an undefined proprietary library.
- Contradicts
- The listed papers do support the general idea that clinically useful protocols can be developed, standardized, and evaluated in systematic reviews and guidelines, including in areas such as cardiovascular patients receiving dental implants and surgical flap design in implant therapy. [12][13][14][15] However, those papers do not validate any Dr. Lum-specific protocol library, and the claim provides no outcomes, comparators, or method details that would allow evidence-based verification. The wording “highly innovative” is also not itself an evidence-based efficacy claim, and the available sources do not show that such a collection is superior to standard guideline-based protocols. The strongest available evidence instead supports protocol development only when it is tied to explicit clinical questions, rigorous methods, and reproducible evaluation.
- Mainstream view
- Mainstream medical and scientific practice treats clinical protocols as evidence-based, indication-specific procedures that should be transparent, reproducible, and supported by systematic review or guideline development. [12][14][15] A vague promotional claim about a proprietary “bonus library” of protocols is not considered medically meaningful without details on content, indications, evidence base, and outcomes.
“A bonus library of tried-and-true, yet highly innovative, clinical protocols developed by Dr. Lum”
Rule: K.S.A. 65-2801 et seq. (chiropractic as a branch of the healing arts, without explicit authority for systemic internal-disease clinical protocols)
Brian Lum is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to advertise many patients struggling with persistent symptoms had an underlying histamine component to their illness as within their scope of practice.
many patients struggling with persistent symptoms had an underlying histamine component to their illness
No specific health claims of theirs were cross-checked against the literature.
“many patients struggling with persistent symptoms had an underlying histamine component to their illness”
Rule: K.S.A. 65-2801 et seq. (healing arts; chiropractic branch scope does not expressly include systemic internal-disease diagnosis)
Brian Lum is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to advertise clinical protocols developed by Dr. Lum as within their scope of practice.
clinical protocols developed by Dr. Lum
- Supports
- The claim is framed as a marketing phrase rather than a testable medical assertion, so there is no direct peer-reviewed evidence in the provided index papers that a “bonus library” of “tried-and-true, yet highly innovative, clinical protocols” developed by Dr. [12][14][15] Lum exists or has clinical value. Major evidence-based sources emphasize that clinical protocols should be specific to a defined question, pre-specified, and transparently developed or registered before use, rather than presented as an undefined proprietary library.
- Contradicts
- The listed papers do support the general idea that clinically useful protocols can be developed, standardized, and evaluated in systematic reviews and guidelines, including in areas such as cardiovascular patients receiving dental implants and surgical flap design in implant therapy. [12][13][14][15] However, those papers do not validate any Dr. Lum-specific protocol library, and the claim provides no outcomes, comparators, or method details that would allow evidence-based verification. The wording “highly innovative” is also not itself an evidence-based efficacy claim, and the available sources do not show that such a collection is superior to standard guideline-based protocols. The strongest available evidence instead supports protocol development only when it is tied to explicit clinical questions, rigorous methods, and reproducible evaluation.
- Mainstream view
- Mainstream medical and scientific practice treats clinical protocols as evidence-based, indication-specific procedures that should be transparent, reproducible, and supported by systematic review or guideline development. [12][14][15] A vague promotional claim about a proprietary “bonus library” of protocols is not considered medically meaningful without details on content, indications, evidence base, and outcomes.
“A bonus library of tried-and-true, yet highly innovative, clinical protocols developed by Dr. Lum”
Rule: K.S.A. 65-2801 et seq. (branch definitions; chiropractic practice not described as including systemic-disease clinical protocols)
Manipulation
transcript · cited
This is a direct product launch, not neutral education. The post steers viewers from a symptom narrative into a paid course enrollment. Likely motive: Sell a self-paced course to an audience primed by chronic-symptom concern.
“Dr. Brian Lum’s new online course is officially available!”
transcript · cited
Listing favorite supplements inside a course signals a downstream product stack. The audience is not just buying knowledge; they are being groomed for branded or recommended supplement purchases. Likely motive: Move viewers from content into supplement buying.
“Dr. Lum’s 5 Favorite Supplements for Healing Histamine”
Commerce & grift map
The likely money flow is: symptom anxiety about histamine/MCAS -> a paid educational course -> supplement recommendations inside the course -> possible future consult or protocol upsell. It’s the classic root-cause funnel with a polished educational veneer: make the condition sound mysterious, then sell the map, then sell the stack.
No paid-promotion disclosure appears on this instagram content. Viewers who arrive directly never learn the creator may be compensated by Dr. Lum’s 5 Favorite Supplements for Healing Histamine.
No on-surface paid-promotion disclosure
vendorDisclosureGap
No paid-promotion disclosure appears on this instagram content. Viewers who arrive directly never learn the creator may be compensated by Dr. Lum’s 5 Favorite Supplements for Healing Histamine.
No FTC-style compensation disclosure
compensationDisclosures · scan
Paid online course enrollment for histamine/MCAS education and protocols.
coaching_program
Supplements pitched
- Dr. Lum’s 5 Favorite Supplements for Healing Histamine
“Dr. Lum’s 5 Favorite Supplements for Healing Histamine”
How the money flows
- Coaching or consult upsellUndisclosed Paid online course enrollment for histamine/MCAS education and protocols. “Visit the link in bio to learn more and enroll.”
“Visit the link in bio to learn more and enroll.”
- Supplement brand dealUndisclosed Supplement recommendations embedded in course content; likely directs buyers toward a recommended stack or dispensary pathway. “Dr. Lum’s 5 Favorite Supplements for Healing Histamine”
“Dr. Lum’s 5 Favorite Supplements for Healing Histamine”
Sponsors and advertisers
Brands, advertisers, and agencies connected to this content, based on what it promotes and discloses.
- Dr. Lum’s 5 Favorite Supplements for Healing HistamineBrand
Named on a surface without a compensation disclosure
Credentials & scope
Glossary: Chiropractor (“Dr.”)
Stated: none · Likely: Chiropractor
Verified against the federal provider registry: D.C. · Chiropractor · KS license 01-05584.
Brian Lum appears to be a chiropractor using the 'Dr.' title plus IFMCP branding to market expertise in histamine intolerance and MCAS, both complex internal-illness topics that sit well outside the usual chiropractic lane. The credential becomes a trust wrapper for a broader functional-medicine sales pitch, not a narrow musculoskeletal practice.
- DC, Doctor of Chiropractic
A state-licensed chiropractic doctorate; it does not grant general medical authority over internal medicine, immunology, allergy, or chronic disease management.
Chiropractic boards generally limit practice to neuromusculoskeletal evaluation and treatment, with adjunctive services varying by state. It does not typically authorize diagnosing or treating systemic conditions like MCAS or histamine intolerance as medical disease management.
Permitted scope vs advertised
Kansas State Board of Healing Arts (Chiropractic) · Confidence: low
Kansas law licenses chiropractors as a branch of the healing arts, but their scope is limited to chiropractic methods focused on the spine, musculoskeletal system, and related structures; it does not affirmatively authorize diagnosis or medical management of systemic internal diseases such as mast-cell or histamine disorders. The Board’s chiropractic rules and Kansas statutes require graduation from a chiropractic college and NBCE exams, but do not expand scope into internal medicine-style primary care or systemic disease management.[6]
What this license permits
- Spinal adjustment and manipulation
- Musculoskeletal evaluation and treatment
- Soft-tissue and rehabilitative care
- Headache care within musculoskeletal scope
13 of 13 advertised activities fall outside permitted scope.
| Advertised | Verdict |
|---|---|
| Listed service Mastering Histamine Intolerance and Mast Cell Activation Syndrome: A Complex Illness Specialist’s Guide Rule: K.A.R. 100-6-4 (Applications for licensure in the healing arts); K.S.A. 65-2801 et seq. (healing arts definitions, not expressly authorizing systemic internal-disease specialty practice for chiropractors) Positioning as a "complex illness specialist" for histamine intolerance and mast cell activation syndrome describes systemic internal disease management that is not affirmatively authorized within Kansas chiropractic scope, which is limited to chiropractic/healing arts as defined by statute and regulation.[6] | Outside scope |
| histamine intolerance and MCAS are often misunderstood Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) | Outside scope |
| course on histamine intolerance and MCAS Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) | Outside scope |
| clear framework for understanding and addressing histamine-related illness Rule: K.S.A. 65-2801 et seq. (healing arts definitions; chiropractic branch limited to chiropractic practice, not systemic internal disease management) Creating a framework for "addressing" histamine-related illness implies clinical management of systemic disease, which is not affirmatively authorized for chiropractors under Kansas chiropractic/healing arts scope focused on chiropractic methods. | Outside scope |
| The 5 Game-Changers for Healing Histamine Rule: K.S.A. 65-2801 et seq. (chiropractic defined as a branch of the healing arts without express authority to treat systemic histamine disorders) Advertising "healing histamine" suggests treatment of a systemic biochemical condition rather than musculoskeletal dysfunction, which Kansas chiropractic law does not affirmatively authorize as part of chiropractic practice. | Outside scope |
| Dr. Lum’s 5 Favorite Supplements for Healing Histamine Rule: K.S.A. 65-2801 et seq. (healing arts definitions; no affirmative language granting chiropractors authority to treat systemic histamine disease) Supplement-based protocols specifically marketed to "heal" histamine represent treatment of a systemic condition; Kansas chiropractic scope does not expressly authorize systemic disease treatment or prescribing-like supplement protocols. | Outside scope |
| bonus library of tried-and-true, yet highly innovative, clinical protocols developed by Dr. Lum Rule: K.S.A. 65-2801 et seq. (chiropractic as a branch of the healing arts, without explicit authority for systemic internal-disease clinical protocols) Describing "clinical protocols" for systemic histamine-related illness goes beyond musculoskeletal chiropractic care and lacks affirmative authorization in Kansas chiropractic scope language. | Outside scope |
| many patients struggling with persistent symptoms had an underlying histamine component to their illness Rule: K.S.A. 65-2801 et seq. (healing arts; chiropractic branch scope does not expressly include systemic internal-disease diagnosis) Identifying an "underlying histamine component" to patients’ illness implies systemic diagnostic assessment of internal disease, which is not affirmatively granted in Kansas chiropractic scope. | Outside scope |
| Diagnosing and treating systemic mast-cell/histamine disease Rule: K.S.A. 65-2801 et seq. (definitions of healing arts; chiropractic practice not defined to include diagnosis and treatment of systemic mast-cell disease) Diagnosis and treatment of systemic mast-cell/histamine disease constitute internal medical practice, and Kansas chiropractic statutes and regulations do not affirmatively authorize chiropractors to manage systemic mast-cell disorders. | Outside scope |
| Internal-medicine style management of chronic illness beyond musculoskeletal care Rule: K.S.A. 65-2801 et seq. (scope of healing arts branches; chiropractic limited and does not list internal-medicine-style chronic-disease management) Providing "internal-medicine style" management of chronic illness beyond musculoskeletal conditions steps outside the affirmatively defined chiropractic branch of the healing arts in Kansas. | Outside scope |
| Supplement-based treatment protocols for a systemic condition Rule: K.S.A. 65-2801 et seq. (healing arts definitions; chiropractic branch does not explicitly authorize systemic condition treatment using supplement protocols) Systemic-condition treatment protocols using supplements amount to medical management of internal disease, without affirmative authorization in Kansas chiropractic scope rules. | Outside scope |
| supplement protocol for histamine symptoms Rule: K.S.A. 65-2801 et seq. (chiropractic scope within healing arts; no express authority to treat histamine-related systemic symptoms via supplement protocols) A supplement protocol for histamine symptoms reflects systemic biochemical disease treatment rather than chiropractic musculoskeletal care, which Kansas law does not affirmatively permit for chiropractors. | Outside scope |
| clinical protocols developed by Dr. Lum Rule: K.S.A. 65-2801 et seq. (branch definitions; chiropractic practice not described as including systemic-disease clinical protocols) If these "clinical protocols" are directed at histamine intolerance/MCAS and systemic chronic illness, they exceed the affirmatively defined chiropractic scope limited to chiropractic techniques and related musculoskeletal care. | Outside scope |
Sources: Kansas State Board of Healing Arts – Home (official), Kansas Administrative Regulations – Applications for licensure by examination (healing arts), Kansas State Board of Healing Arts, Licensing | KS Board of Healing Arts website (official)
Validated associated properties
Surfaces tied to this Doc Bro by domain, branding, or funnel routing. Third-party platforms are labeled as routes, not as owned properties.
Analyzed
- OwnedOfficial site (drbrianlum.com)
Tip the jar
Report useful? Optional tips help keep scans, archives, and literature cross-checks running. They never change conclusions.
Submission pioeaVk2N5sF90ORDrd1v
Fight disinformation
Log a public thread where Brian Lum is spreading nonsense, get a copy-paste reply with this report link.
Reply snippets
Before you buy the protocol: Dr. Trust Me Bro fact-checked Brian Lum's claims with peer-reviewed sources, https://drtrustmebro.com/analyze/pioeaVk2N5sF90ORDrd1v. White-coat charisma isn't evidence.
Full DTMB scan on Brian Lum: https://drtrustmebro.com/analyze/pioeaVk2N5sF90ORDrd1v
Drop these in YouTube comments, Reddit threads, and forums, link back to this scan, not vibes.
Recent mentions (this doc)
No conversation links logged yet. Be the first above.
Nudge the Doc Bro
We could not find a public contact email for Brian Lum. Reach them through their own site and ask them to review this dossier and correct anything we got wrong.
Know someone who can help?
If you think someone has firsthand information about Brian Lum, send them an encouraging note. We email a short, respectful message with this report and clear instructions on how to write in, on the record or anonymously.
Whambulance
Challenge this scan or Wall of Fame entry for Brian Lum. Public log, not legal arbitration.
Public challenge log
No posted Wall of Fame challenges linked yet.
Challenges are public on the Wall of Fame card. DTMB does not remove entries for hurt feelings, primary sources or copy corrections only.
File a challenge
Include in your email:
- Doc Bro ID: zavjCnJ_WnMq1X5wHu4iH
- Wall entry: /influencer/zavjCnJ_WnMq1X5wHu4iH
- Analysis ID: pioeaVk2N5sF90ORDrd1v
- Source: https://www.instagram.com/p/DVwQF2nF9gj/
- Why this entry or scan should change
- Supporting links (one per line)
- Your business email (for verified disputes)
Verified challenges are posted publicly on the report. Public log, not legal arbitration.
Citations
Peer-reviewed and index sources cited in this report.
- [1] Spectrum, Time Course, Stages, and a Proposal for the Diagnosis of Histamine Intolerance in General Practice: A Nonrandomized, Quasi-Experimental Study
- [2] Guideline on management of suspected adverse reactions to ingested histamine
- [3] Guideline on management of suspected adverse reactions to ingested histamine
- [4] German guideline for the management of adverse reactions to ingested histamine
- [5] PubMed indexed study
- [6] PubMed indexed study
- [7] Histamine Intolerance—The More We Know the Less We Know. A Review
- [8] Histamine Intolerance: The Current State of the Art
- [9] Study Protocol for a Prospective, Unicentric, Double-Blind, Randomized, and Placebo-Controlled Trial on the Efficacy of a Low-Histamine Diet and DAO Enzyme Supplementation in Patients with Histamine Intolerance
- [10] Diamine oxidase supplementation improves symptoms in patients with histamine intolerance
- [11] The dietary treatment of histamine intolerance reduces the abundance of some histamine-secreting bacteria of the gut microbiota in histamine intolerant women. A pilot study
- [12] Official American Thoracic Society/Japanese Respiratory Society Clinical Practice Guidelines: Lymphangioleiomyomatosis Diagnosis and Management.
- [13] Dorzagliatin add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 3 trial
- [14] Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
- [15] How to prepare and manage a systematic review and meta-analysis of clinical studies